CD19 and congenital rubella syndrome: She was enrolled in a clinical trial for CD19 chimeric antigen receptor (CAR) T cell immunotherapy and exhibited high fever before being placed on a ventilator for two weeks whilst the clinicians monitored and treated her CRS (7).